Chronic Low Back Pain Clinical Trial
Official title:
A Zhineng Qigong Intervention for Patients With Chronic Low Back Pain and/or Leg Pain
Verified date | August 2020 |
Source | Lund University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to evaluate a Zhineng Qigong intervention for patients with chronic low back pain and/or leg pain, and to test feasibility aspects.
Status | Completed |
Enrollment | 55 |
Est. completion date | December 2014 |
Est. primary completion date | June 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
General inclusion criteria: - Low back pain and/or leg pain (caused by lumbar disorder) with at least 3 months duration. - Pain intensity in lumbar spine and/or leg (caused by lumbar disorder) at least 30 on a 0-100 Visual Analogue Scale (VAS), being "the best description of pain the past 2 weeks". (As enrolment initially went slow, also patients scoring VAS pain intensity 25 to 30 became eligible if their pain situations were qualitatively assessed severe, resulting in enrolment of 5 such patients). - Resident in the county of SkƄne (southern part of Sweden). - Comfortable with the Swedish language. - Acceptance not to practise Yoga, Meditation, or any other Qigong exercises during or 1 month after the intervention. Specific inclusion criteria, clinical pathway: - Postoperative after lumbar spine surgery: one lumbar spine surgery 1-6 years earlier, for either spinal stenosis, spondylolisthesis, or segmental pain. Pain intensity (back and/or leg) at least 30 on 0-100 mm VAS in latest SweSpine follow-up protocol. - Patients from Primary Healthcare Centres: chronic low back pain (at least 3 months duration) with or without leg pain. - Patients on waiting list for lumbar spine surgery: Planned first surgery for either spinal stenosis, spondylolisthesis, or segmental pain. Exclusion criteria: - Lumbar spine or other major surgery planned before, during, or within 1 month after the intervention period. - History of serious mental disease, epilepsy, or narcolepsy. - Current abuse of medicament, drug, or alcohol. - Pregnancy (due to practical reasons only). |
Country | Name | City | State |
---|---|---|---|
Sweden | Primary Healthcare Centre Dalby | Dalby | |
Sweden | Primary Healthcare Centre Löddeköpinge | Löddeköpinge | |
Sweden | Primary Healthcare Centre Capio Citykliniken Clemenstorget | Lund | |
Sweden | Primary Healthcare Centre Laurentiikliniken | Lund | |
Sweden | Primary Healthcare Centre Linero/Östra Torn | Lund | |
Sweden | Primary Healthcare Centre Måsen | Lund | |
Sweden | Primary Healthcare Centre Nöbbelöv | Lund | |
Sweden | Orthopaedic clinic, Skåne University Hospital | Malmö | |
Sweden | Primary Healthcare Centre Södra Sandby | Södra Sandby |
Lead Sponsor | Collaborator |
---|---|
Lund University | Ekhaga foundation, Greta and Johan Kock Foundation, The Swedish Institute for Health Sciences |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Concomitant disorders | Concomitant disorders/major health complaints/symptoms other than related to the lumbar spine. Question designed for this study, with checkboxes for common disorders. | Before intervention and as soon as possible after | |
Other | Physical activities | Type and amount of performed physical activities, question designed for this study. | At baseline concerning past 3 months, after intervention since intervention start | |
Other | Treatments | Type and amount of received treatments, question designed for this study. | At baseline concerning past 3 months, after intervention since intervention start | |
Other | Work status | Work status (Full-time, Part-time, Not working), and the reason not to work full-time. Question designed for this study. | Before intervention and as soon as possible after | |
Primary | Pain intensity | "Pain diary" (designed for this study) measured most usual pain intensity (NRS; 0-10) in lumbar spine and/or leg (caused by lumbar spine disorder). | Filled in once daily during 2 weeks, directly before and directly after the intervention period, respectively | |
Secondary | Pain symptoms | Question (designed for this study) with checkboxes for selecting common lumbar spine-related pain symptoms. | Before intervention and as soon as possible after | |
Secondary | Non-pain symptoms | Question (designed for this study) with checkboxes for selecting common lumbar spine-related non-pain symptoms. | Before intervention and as soon as possible after | |
Secondary | How often "free from pain" | Question (designed for this study) with options "Almost never" to "Completely free". | Before intervention and as soon as possible after | |
Secondary | How often "free from non-pain symptoms" | Question (designed for this study) with options "Almost never" to "Completely free". | Before intervention and as soon as possible after | |
Secondary | Change in intake of analgesics | Question (designed for this study) with options. | At baseline concerning past 3 months, after intervention since intervention start | |
Secondary | Change in intake of other medications | Question (designed for this study) with options. | At baseline concerning past 3 months, after intervention since intervention start | |
Secondary | Healthcare utilisation | Number of visits to physicians, nurses, physiotherapists, occupational therapists, and others. Question designed for this study. | At baseline concerning past 3 months, after intervention since intervention start | |
Secondary | Performed lumbar spine surgery | Follow-up if planned surgery was performed, for respondents on waiting list for lumbar spine surgery. | 6 months after intervention | |
Secondary | Walking ability | The respondent walked 10 meters and back, gait performance was noted ("normal gait", "slight limping", or "severe limping"). | Before and after the intervention period | |
Secondary | Active cervical range of motion | Flexion, extension, rotation, and lateral flexion measured using Myrin inclinometer. | Before and after the intervention period | |
Secondary | Active maximal functional shoulder mobility | Active shoulder flexion and "hand on neck" were measured using goniometer. "Hand on back" position was noted ("buttocks"; "lumbosacral"; "thoracolumbar"; and, "between scapulae"). | Before and after the intervention period | |
Secondary | Passive hip mobility | Hip flexion, and external and internal rotation were measured using goniometer. Extension was assessed as normal or reduced. | Before and after the intervention period | |
Secondary | Finger tip-floor distance | Flexion of lumbar spine with straight knees, with direction of fingers towards the floor in front of the feet. The distance between the middle finger tips and the floor was measured using tape measure. | Before and after the intervention period | |
Secondary | Schober test | The respondent was asked to do a lumbar flexion with straight knees to a self-chosen range and the increased distance between two skin marks (made at level S1 and 10 centimetres cranially) was registered using tape measure. | Before and after the intervention period | |
Secondary | Single leg stance | A functional test for balance. The respondent lifted each foot to a standard height of 20 centimetres and tried to maintain the position for 30 seconds. Timed scores were recorded with a digital stop watch. | Before and after the intervention period | |
Secondary | Timed get-up-and-go | A test for functional mobility. The respondent sat in a chair and at a verbal signal, the respondent stood up without using hands and walked to a point 3 meters in front, then turned around, walked back and sat down again without using hands. Timed scores were recorded with a digital stop watch. | Before and after the intervention period | |
Secondary | Straight leg raising test | The flexion angle of each hip was measured using Myrin inclinometer placed on the ankle joint. Also, eventual pain radiating to the leg and/or low back pain was registered. | Before and after the intervention period | |
Secondary | Oswestry Disability Index version 2.1a | Questionnaire assessing spine-related disability "for today". | Before intervention and as soon as possible after | |
Secondary | Short Form 36 version 2 | Questionnaire assessing generic Health-Related Qualify of Life (standard 4-week recall). | Before intervention and as soon as possible after | |
Secondary | EQ-5D-5L (including EQ VAS) | Questionnaire assessing generic Health-Related Qualify of Life "for the day". | Before intervention and as soon as possible after | |
Secondary | Additional aspects concerning Health-Related Qualify of Life | Questions (designed for this study) evaluating perceived concentration ability, distress, sleeping quality, energy level, sadness/depression, irritability, and tension/anxiety, respectively, "the past week" (NRS; 0-10). | Before intervention and as soon as possible after | |
Secondary | Recruitment rate | The percentage of enrolled patients among those who early were estimated to be eligible. | Before intervention | |
Secondary | Retention rate | The percentage of patients who completed the study among those who were enrolled. | After intervention | |
Secondary | Attendance in group activities | Attended hours in group activities were registered. | During intervention | |
Secondary | Individual Zhineng Qigong training time | Training diary (designed for this study) with individual daily Zhineng Qigong training time (minutes), besides group activities. | During intervention and 2 weeks after intervention | |
Secondary | Ability to collect outcome measures | The percentage of completed outcome measures. | At baseline and after intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 |